Record Revenue Highlighted by 70% Growth in Single-Use Navigation and Therapy Products SOLANA BEACH, CALIFORNIA / ACCESS Newswire / May 13, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), ...

Collectively, the data from in vitro and in vivo studies using FUS, TDP-43, and C9orf72 models demonstrate that hUPF1 holds significant potential for treating the majority of patients with ALS and ...

The AAV9-CaMKIIα0.4 vector eliminated viral shedding in 90% of treated eyes and reduced TG HSV-1 DNA by 51%. The presentations can be accessed on the Excision website at ...

The event brought together thought leaders advancing health-system pharmacy in the management, delivery, and optimization of advanced therapeutics.

Melbourne’s Peter MacCallum Cancer Centre – aka Peter Mac – is Australia’s only public hospital dedicated to cancer care, ...

Mitochondrial DNA (mtDNA) editing has emerged as a revolutionary approach in the fight against neurodegenerative diseases (NDDs).

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / May 12, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation ...

Preeclampsia is a complication characterised by high blood pressure and organ damage, arising during the second half of ...

Early detection is key to survival, but requires urgent awareness, better healthcare access, and Africa-specific genetic ...

Children's Wisconsin says it accidentally ‘discarded’ the frozen portion of a young woman's donated brain. Ashtyn Fellenz, ...